Role of type 3 deiodinase in cancer

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 11, 2009, Pages 1363-1373

  Dentice, Monica ^a   Ambrosio, Raffaele ^b   Salvatore, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS SDN   (Italy)

Author keywords

cancer; deiodinase; differentiation; thyroid hormone

Indexed keywords

CCAAT BINDING FACTOR; CELL NUCLEUS RECEPTOR; CYCLIN A1; CYCLIN A2; CYCLIN DEPENDENT KINASE 2; DITHIOTHREITOL; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FIBROBLAST GROWTH FACTOR; GLYCOSIDASE; IOPANOIC ACID; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; NUCLEOTIDE; PEPTIDES AND PROTEINS; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER DERIVATIVE; PROPYLTHIOURACIL; RETINOID X RECEPTOR; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SONIC HEDGEHOG PROTEIN; THYROID HORMONE DERIVATIVE; THYROID HORMONE RECEPTOR; THYROXINE; TRANSFORMING GROWTH FACTOR BETA; TYPE 3 IODOTHYRONINE DEIODINASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE III; TUMOR MARKER;

5' UNTRANSLATED REGION; ANGIOGENESIS; APOPTOSIS; ASTROCYTE; ASTROCYTOMA; BASAL CELL CARCINOMA; BRAIN; BRAIN CORTEX; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CAPILLARY HEMANGIOMA; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CENTRAL NERVOUS SYSTEM; CHROMOSOME; CHROMOSOME 14; CHROMOSOME 3P; CLEARANCE; COLON CARCINOMA; CONNECTIVE TISSUE CELL; DNA STRAND; DOWN REGULATION; EMBRYO DEVELOPMENT; ENDOCRINE DISEASE; ENDOMETRIUM CARCINOMA; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; ERYTHROBLASTOSIS; ERYTHROID PRECURSOR CELL; EXON; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; GLIA CELL; GLIOBLASTOMA; GLIOSARCOMA; GONAD; GROWTH RETARDATION; HAIR GROWTH; HALF LIFE TIME; HEAD AND NECK CANCER; HEART; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HETEROZYGOSITY LOSS; HOMEOSTASIS; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFERTILITY; INTESTINE; KERATINOCYTE; KIDNEY CARCINOMA; LIVER; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LUNG; LUNG SMALL CELL CANCER; MELANOMA; METASTASIS; MYOBLAST; NEOPLASM; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; ONCOGENE C FOS; OVARY CANCER; PARACRINE SIGNALING; PERINATAL MORTALITY; PHYLOGENETIC TREE; PLACENTA; PLACENTAL TRANSFER; POLYADENYLATION; PROADIPOCYTE; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW; RNA SPLICING; SERTOLI CELL; SKELETAL MUSCLE; SKIN; STOMACH CANCER; TATA BOX; TELOMERE; TESTIS CANCER; THYROID FOLLICULAR CARCINOMA; THYROID HORMONE METABOLISM; THYROTROPIN SECRETING ADENOMA; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR GROWTH; UNIPARENTAL DISOMY; UPREGULATION; URINARY TRACT; UTERINE CERVIX CARCINOMA; VASCULAR TUMOR; WOUND HEALING; ANIMAL; DRUG DELIVERY SYSTEM; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; IODIDE PEROXIDASE; NEOPLASMS; SIGNAL TRANSDUCTION; THYROXINE; TRIIODOTHYRONINE; TUMOR MARKERS, BIOLOGICAL;

EID: 73449112686     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728220903339122     Document Type: Review

References (100)

1. Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23(1):38-89 (Pubitemid 34185306)
2. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008;29(7):898-938
3. Gereben B, Zeold A, Dentice M, et al. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci 2008;65(4):570-90
4. Campos-Barros A, Hoell T, Musa A, et al. Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J Clin Endocrinol Metab 1996;81(6):2179-85 (Pubitemid 26175943)
5. Huang TS, Chopra IJ, Beredo A, et al. Skin is an active site for the inner ring monodeiodination of thyroxine to 3,3′,5′- triiodothyronine. Endocrinology 1985;117(5):2106-13 (Pubitemid 16194268)
6. Hernandez A, Martinez ME, Fiering S, et al. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 2006;116(2):476-84 (Pubitemid 43228365)
7. Baqui M, Botero D, Gereben B, et al. Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J Biol Chem 2003;278(2):1206-11 (Pubitemid 36790803)
8. Callebaut I, Curcio-Morelli C, Mornon J P, et al. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem 2003;278(38):36887-96 (Pubitemid 37140023)
9. Salvatore D, Low SC, Berry M, et al. Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest 1995;96(5):2421-30
10. Curcio-Morelli C, Gereben B, Zavacki AM, et al. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology 2003;144(3):937-46 (Pubitemid 36262861)
11. Hernandez A, Park J P, Lyon GJ, et al. Localization of the type 3 iodothyronine deiodinase (DIO3) gene to human chromosome 14q32 and mouse chromosome 12F1. Genomics 1998;53(1):119-21 (Pubitemid 28489657)
12. Yevtodiyenko A, Carr MS, Patel N, Schmidt JV. Analysis of candidate imprinted genes linked to Dlk1-Gtl2 using a congenic mouse line. Mamm Genome 2002;13(11):633-8 (Pubitemid 35398939)
13. Tsai CE, Lin S P, Ito M, et al. Genomic imprinting contributes to thyroid hormone metabolism in the mouse embryo. Curr Biol 2002;12(14):1221-6 (Pubitemid 34801170)
14. Sutton VR, Shaffer LG. Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. Am J Med Genet 2000;93(5):381-7 (Pubitemid 30622183)
15. Hernandez A, Martinez ME, Croteau W, St Germain DL. Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus. Genomics 2004;83(3):413-24 (Pubitemid 38220846)
16. Van der Geyten S, Sanders J P, Kaptein E, et al. Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development. Endocrinology 1997;138(12):5144-52 (Pubitemid 27509671)
17. Van der Geyten S, Segers I, Gereben B, et al. Transcriptional regulation of iodothyronine deiodinases during embryonic development. Mol Cell Endocrinol 2001;183(1-2):1-9 (Pubitemid 32943546)
18. Van der Geyten S, Van den Eynde I, Segers IB, et al. Differential expression of iodothyronine deiodinases in chicken tissues during the last week of embryonic development. Gen Comp Endocrinol 2002;128(1):65-73
19. Bates JM, St Germain DL, Galton VA. Expression profles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 1999;140(2):844-51 (Pubitemid 29058221)
20. Huang TS, Beredo A, Solomon DH, Chopra IJ. The inner ring (5-) monodeiodination of thyroxine (T4) in cerebral cortex during fetal, neonatal, and adult life. Metabolism 1986;35(3):272-7 (Pubitemid 16137637)
21. Kaplan MM, Yaskoski KA. Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest 1980;66(3):551-62 (Pubitemid 10053920)
22. Lee JK, Gordon PR, Stall GM, et al. Phenolic and tyrosyl ring iodothyronine deiodination by the caco-2 human colon carcinoma cell line. Metabolism 1989;38(12):1154-61 (Pubitemid 20015487)
23. Sorimachi K, Robbins J. Metabolism of thyroid hormones by cultured monkey hepatocarcinoma cells. Nonphenolic ring dieodination and sulfation. J Biol Chem 1977;252(13):4458-63 (Pubitemid 8155961)
24. Nauman P, Bonicki W, Michalik R, et al. The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas. Folia Neuropathol 2004;42(2):67-73 (Pubitemid 38979241)
25. Mori K, Yoshida K, Kayama T, et al. Thyroxine 5-deiodinase in human brain tumors. J Clin Endocrinol Metab 1993;77(5):1198-202 (Pubitemid 23345469)
26. Dentice M, Luongo C, Huang S, et al. Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci USA 2007;104(36):14466-71 (Pubitemid 350003284)
27. Huang SA, Fish SA, Dorfman DM, et al. A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab 2002;87(10):4457-61 (Pubitemid 35247024)
28. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000;343(3):185-9 (Pubitemid 30489216)
29. Hernandez A, St Germain DL, Obregon MJ. Transcriptional activation of type III inner ring deiodinase by growth factors in cultured rat brown adipocytes. Endocrinology 1998;139(2):634-9 (Pubitemid 28513213)
30. Courtin F, Liva P, Gavaret JM, et al. Induction of 5-deiodinase activity in astroglial cells by 12-O-tetradecanoylphorbol 13-acetate and fbroblast growth factors. J Neurochem 1991;56(4):1107-13 (Pubitemid 21902024)
31. Huang SA, Mulcahey MA, Crescenzi A, et al. Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Mol Endocrinol 2005;19(12):3126-36 (Pubitemid 41697726)
32. Kester MH, Kuiper GG, Versteeg R, Visser TJ. Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 2006;147(12):5845-54 (Pubitemid 44833501)
33. Meyer EL, Wagner MS, Maia AL. Iodothyronine deiodinases expression in thyroid neoplasias. Arq Bras Endocrinol Metabol 2007;51(5):690-700
34. Tu HM, Legradi G, Bartha T, et al. Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 1999;140(2):784-90 (Pubitemid 29058213)
35. Escobar-Morreale H F, Obregon MJ, Hernandez A, et al. Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine. Endocrinology 1997;138(6):2559-68 (Pubitemid 27215263)
36. Marsh-Armstrong N, Huang H, Remo B F, et al. Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase. Neuron 1999;24(4):871-8 (Pubitemid 30017666)
37. Hernandez A, Obregon MJ. Presence of growth factors-induced type III iodothyronine 5-deiodinase in cultured rat brown adipocytes. Endocrinology 1995;136(10):4543-50
38. Hernandez A, St Germain DL. Dexamethasone inhibits growth factor-induced type 3 deiodinase activity and mRNA expression in a cultured cell line derived from rat neonatal brown fat vascular-stromal cells. Endocrinology 2002;143(7):2652-8 (Pubitemid 34701328)
39. Pallaud C, Maurice M, Cheng S, et al. Multilocus approach to cardiovascular risk. Scand J Clin Lab Invest Suppl 1999;230:168-76 (Pubitemid 29279369)
40. Hernandez A, St Germain DL. Activity and response to serum of the mammalian thyroid hormone deiodinase 3 gene promoter: identifcation of a conserved enhancer. Mol Cell Endocrinol 2003;206(1-2):23-32 (Pubitemid 37011250)
41. Auchus RJ. The genetics, pathophysiology, and management of human defciencies of P450c17. Endocrinol Metab Clin North Am 2001;30(1):101-19, vii (Pubitemid 32381716)
42. Hernandez A, Garcia B, Obregon MJ. Gene expression from the imprinted Dio3 locus is associated with cell proliferation of cultured brown adipocytes. Endocrinology 2007;148(8):3968-76 (Pubitemid 47105881)
43. Perez-Castillo A, Hernandez A, Pipaon C, et al. Multiple regulation of S14 gene expression during brown fat differentiation. Endocrinology 1993;133(2):545-52 (Pubitemid 23238862)
44. Hernandez A, Obregon MJ. T3 potentiates the adrenergic stimulation of type II 5′-deiodinase activity in cultured rat brown adipocytes. Am J Physiol 1996;271(1 Pt 1):E15-23
45. Hernandez A, Obregon MJ. Triiodothyronine amplifes the adrenergic stimulation of uncoupling protein expression in rat brown adipocytes. Am J Physiol Endocrinol Metab 2000;278(5):E769-77 (Pubitemid 30366392)
46. Safer JD, Crawford TM, Fraser LM, et al. Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration. Thyroid 2003;13(2):159-65 (Pubitemid 36596713)
47. Schrader M, Carlberg C. Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes, and inverted palindromes. DNA Cell Biol 1994;13(4):333-41 (Pubitemid 24295363)
48. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Struct Biol 2001;11(1):33-8 (Pubitemid 32155549)
49. Beatson CT. On treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 1896;2:104-7
50. Sap J, Munoz A, Damm K, et al. The c-erb-A protein is a high-affnity receptor for thyroid hormone. Nature 1986;324(6098):635-40 (Pubitemid 17206350)
51. Weinberger C, Thompson CC, Ong ES, et al. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986;324(6098):641-6 (Pubitemid 17206351)
52. Sap J, Munoz A, Schmitt J, et al. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature 1989;340(6230):242-4 (Pubitemid 19171590)
53. Thormeyer D, Baniahmad A. The v-erbA oncogene (review). Int J Mol Med 1999;4(4):351-8
54. Barlow C, Meister B, Lardelli M, et al. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J 1994;13(18):4241-50 (Pubitemid 24295196)
55. Too CK, Guernsey DL. Elevation of the thyroid hormone receptor erb A-alpha 2 mRNA in transformed rodent cells is due to increased message stability. Cancer Lett 1993;70(3):151-7 (Pubitemid 23238680)
56. Smyth P P. The thyroid and breast cancer: a signifcant association? Ann Med 1997;29(3):189-91 (Pubitemid 27292526)
57. Leduc F, Brauch H, Hajj C, et al. Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. Am J Hum Genet 1989;44(2):282-7 (Pubitemid 19045024)
58. Sisley K, Curtis D, Rennie IG, Rees RC. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma. Melanoma Res 1993;3(6):457-61 (Pubitemid 24051369)
59. Chen LC, Matsumura K, Deng G, et al. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 1994;54(11):3021-4 (Pubitemid 24187790)
60. Dobrovic A, Houle B, Belouchi A, Bradley WE. erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma. Cancer Res 1988;48(3):682-5 (Pubitemid 18056543)
61. Drabkin H, Kao FT, Hartz J, et al. Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci USA 1988;85(23):9258-62 (Pubitemid 19001876)
62. Huber-Gieseke T, Pernin A, Huber O, et al. Lack of loss of heterozygosity at the c-erbA beta locus in gastrointestinal tumors. Oncology 1997;54(3):214-9 (Pubitemid 27160588)
63. Futreal PA, Soderkvist P, Marks JR, et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 1992;52(9):2624-7
64. Yokota J, Yamamoto T, Miyajima N, et al. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplifcation of the v-erbA homologue. Oncogene 1988;2(3):283-7 (Pubitemid 18085309)
65. Wang CS, Lin KH, Hsu YC. Alterations of thyroid hormone receptor alpha gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett 2002;175(2):121-7
66. Dayton AI, Terwilliger E F, Potz J, et al. Cis-acting sequences responsive to the rev gene product of the human immunodefciency virus. J Acquir Immune Defc Syndr 1988;1(5):441-52 (Pubitemid 19129851)
67. Cerbon MA, Pichon M F, Milgrom E. Thyroid hormone receptors in human breast cancer. Cancer Res 1981;41(10):4167-73 (Pubitemid 11011214)
68. Alvarado-Pisani AR, Chacon RS, Betancourt LJ, Lopez-Herrera L. Thyroid hormone receptors in human breast cancer: effect of thyroxine administration. Anticancer Res 1986;6(6):1347-51
69. Burke RE, McGuire WL. Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res 1978;38(11 Pt 1):3769-73 (Pubitemid 9045204)
70. Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, et al. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Endocrinology 1992;130(3):1145-52
71. Lopez-Barahona M, Fialka I, Gonzalez-Sancho JM, et al. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J 1995;14(6):1145-55
72. Gonzalez-Sancho JM, Alvarez-Dolado M, Caelles C, Munoz A. Inhibition of tenascin-C expression in mammary epithelial cells by thyroid hormone. Mol Carcinog 1999;24(2):99-107 (Pubitemid 29115912)
73. Silva JM, Dominguez G, Gonzalez-Sancho JM, et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 2002;21(27):4307-16 (Pubitemid 34753837)
74. Arbuthnot P, Kew M, Parker I, Fitschen W. Expression of c-erbA in human hepatocellular carcinomas. Anticancer Res 1989;9(4):885-7
75. Lin KH, Shieh HY, Chen SL, Hsu HC. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 1999;26(1):53-61
76. Lin KH, Zhu XG, Shieh HY, et al. Identifcation of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line. Endocrinology 1996;137(10):4073-81
77. Puzianowska-Kuznicka M, Krystyniak A, Madej A, et al. Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 2002;87(3):1120-8 (Pubitemid 36121076)
78. Wang CJ, Howng SL, Lin KH. Expression of thyroid hormone receptors in human pituitary tumor cells. Cancer Lett 1995;91(1):79-83
79. Gittoes NJ, McCabe CJ, Verhaeg J, et al. Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary. J Clin Endocrinol Metab 1997;82(6):1960-7 (Pubitemid 127495218)
80. McCabe CJ, Gittoes NJ, Sheppard MC, Franklyn JA. Thyroid receptor alpha1 and alpha2 mutations in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 1999;84(2):649-53 (Pubitemid 29075700)
81. Ando S, Sarlis NJ, Oldfeld EH, Yen PM. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 2001;86(11):5572-6 (Pubitemid 33070290)
82. Su Y, Damjanovski S, Shi Y, Shi YB. Molecular and cellular basis of tissue remodeling during amphibian metamorphosis. Histol Histopathol 1999;14(1):175-83 (Pubitemid 29049366)
83. Francavilla A, Carr BI, Azzarone A, et al. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 1994;20(5):1237-41 (Pubitemid 24323572)
84. Malik R, Mellor N, Selden C, Hodgson H. Triiodothyronine enhances the regenerative capacity of the liver following partial hepatectomy. Hepatology 2003;37(1):79-86 (Pubitemid 36042148)
85. Safer JD, Crawford TM, Holick M F. Topical thyroid hormone accelerates wound healing in mice. Endocrinology 2005;146(10):4425-30 (Pubitemid 41324040)
86. Ohmura T, Katyal SL, Locker J, et al. Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3′,5-triiodo-L-thyronine. Cancer Res 1997;57(5):795-8 (Pubitemid 27097995)
87. Kassem M, Mosekilde L, Eriksen E F. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem Mol Biol Int 1993;30(4):779-88 (Pubitemid 23250524)
88. Foster M P, Montecino-Rodriguez E, Dorshkind K. Proliferation of bone marrow pro-B cells is dependent on stimulation by the pituitary/thyroid axis. J Immunol 1999;163(11):5883-90
89. Baas D, Bourbeau D, Sarlieve LL, et al. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 1997;19(4):324-32 (Pubitemid 27165239)
90. Bauer A, Mikulits W, Lagger G, et al. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J 1998;17(15):4291-303 (Pubitemid 28362620)
91. Palmero S, Prati M, Bolla F, Fugassa E. Tri-iodothyronine directly affects rat Sertoli cell proliferation and differentiation. J Endocrinol 1995;145(2):355-62
92. Garcia-Silva S, Aranda A. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 2004;24(17):7514-23 (Pubitemid 39121479)
93. Visser TJ, Schoenmakers CH. Characteristics of type III iodothyronine deiodinase. Acta Med Austriaca 1992;19(Suppl 1):18-21
94. Wood WM, Sarapura VD, Dowding JM, et al. Early gene expression changes preceding thyroid hormone-induced involution of a thyrotrope tumor. Endocrinology 2002;143(2):347-59 (Pubitemid 34107186)
95. Puzianowska-Kuznicka M, Pietrzak M, Turowska O, Nauman A. Thyroid hormones and their receptors in the regulation of cell proliferation. Acta Biochim Pol 2006;53(4):641-50 (Pubitemid 46090114)
96. Fujieda M, Murata Y, Hayashi H, et al. Effect of thyroid hormone on epidermal growth factor gene expression in mouse submandibular gland. Endocrinology 1993;132(1):121-5 (Pubitemid 23019491)
97. Humes HD, Cieslinski DA, Johnson LB, Sanchez IO. Triiodothyronine enhances renal tubule cell replication by stimulating EGF receptor gene expression. Am J Physiol 1992;262(4 Pt 2):F540-5
98. Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH. Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol Cell Biol 1999;19(1):864-72 (Pubitemid 29018487)
99. Perez-Juste G, Aranda A. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem 1999;274(8):5026-31
100. Yen CC, Huang YH, Liao CY, et al. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol 2006;36(1):9-21